Vinicius Taioqui Pelá | Clinical Biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Dr. Vinicius Taioqui Pelá | Clinical Biotechnology | Best Researcher Award

Prof. Dr. Vinicius Taioqui Pelá is a distinguished academic and researcher recognized for his contributions to the fields of biochemistry, molecular biology, and oral biology, with a strong focus on innovative strategies for dental health. Prof. Dr. Vinicius Taioqui Pelá pursued his academic formation in biology, oral biology, genetics, and evolution, completing advanced studies that included international research training, and further enhanced his expertise through postdoctoral research in biological sciences at the University of São Paulo. Prof. Dr. Vinicius Taioqui Pelá has accumulated significant experience as a collaborating professor and researcher, actively contributing to undergraduate and postgraduate teaching, mentoring scientific initiation projects, and participating in pedagogical support programs in biochemistry at the Bauru School of Dentistry. Prof. Dr. Vinicius Taioqui Pelá has established himself as an expert in the development of dental products such as rinses, orodispersible films, and gels, as well as in mass spectrometry, proteomics, recombinant proteins, and metalloproteinase analysis, with his work addressing critical challenges in erosive tooth wear and dental caries. His academic productivity includes more than thirty scientific articles, numerous conference presentations, participation in international congresses, and active involvement in scientific boards and reviewing activities, with recognition through awards, interviews, and invited lectures. Prof. Dr. Vinicius Taioqui Pelá has also been honored with distinctions such as the CAPES Thesis Award honorable mention and the Young Innovators Award for his groundbreaking research on mouthwash development. With research interests centered on engineering the acquired pellicle, designing recombinant proteins, and evaluating protective mechanisms against dental erosion, Prof. Dr. Vinicius Taioqui Pelá integrates laboratory research with clinical applications, contributing to advancements in preventive dentistry and biomaterial innovation. His projects often involve collaboration with students, national institutions, and international partners, reflecting his commitment to advancing knowledge and training future researchers in biochemistry and oral health sciences. Prof. Dr. Vinicius Taioqui Pelá’s scientific impact is reflected in his growing citation record and h-index, demonstrating the relevance and influence of his research in the global scientific community. In conclusion, Prof. Dr. Vinicius Taioqui Pelá stands as a dedicated scholar whose career embodies academic excellence, research innovation, and a commitment to advancing oral biology through education, collaboration, and scientific discovery.

Profile: Scopus | Google Scholar

Featured Publications

Santiago, A. C., Khan, Z. N., Miguel, M. C., Gironda, C. C., Soares-Costa, A., Pelá, V. T., … Buzalaf, M. A. R. (2017). A new sugarcane cystatin strongly binds to dental enamel and reduces erosion. Journal of Dental Research, 96(9), 1051–1057.

Zarella, B. L., Cardoso, C. A. B., Pelá, V. T., Kato, M. T., Tjäderhane, L., & Buzalaf, M. A. R. (2015). The role of matrix metalloproteinases and cysteine-cathepsins on the progression of dentine erosion. Archives of Oral Biology, 60(9), 1340–1345.

Carvalho, T. S., Araujo, T. T., Ventura, T. M. O., Dionizio, A., Câmara, J. V. F., Pelá, V. T., … Buzalaf, M. A. R. (2020). Acquired pellicle protein-based engineering protects against erosive demineralization. Journal of Dentistry, 102, 103478.

Pelá, V. T., Buzalaf, M. A. R., Niemeyer, S. H., Baumann, T., Henrique-Silva, F., & Carvalho, T. S. (2021). Acquired pellicle engineering with proteins/peptides: Mechanism of action on native human enamel surface. Journal of Dentistry, 107, 103612.

Braga, A. S., Girotti, L. D., de Melo Simas, L. L., Pires, J. G., Pelá, V. T., Buzalaf, M. A. R., … Magalhães, A. C. (2019). Effect of commercial herbal toothpastes and mouth rinses on the prevention of enamel demineralization using a microcosm biofilm model. Biofouling, 35(7), 796–804.

Pelá, V. T., Lunardelli, J. G. Q., Tokuhara, C. K., Gironda, C. C., Silva, N. D. G., … Buzalaf, M. A. R. (2021). Safety and in situ antierosive effect of CaneCPI-5 on dental enamel. Journal of Dental Research, 100(12), 1344–1350.

Pelá, V. T., Cassiano, L. P. S., Ventura, T. M. S., Souza-e-Silva, C. M., Gironda, C. C., … Buzalaf, M. A. R. (2018). Proteomic analysis of the acquired enamel pellicle formed on human and bovine tooth: A study using the Bauru in situ pellicle model (BISPM). Journal of Applied Oral Science, 27, e20180113.

WEI CAO | Clinical Biotechnology | Young Researcher Award

Published on by Biotechnology Scientist

Prof. WEI CAO | Clinical Biotechnology | Young Researcher Award

Professor | Shanghai Jiao Tong University School of Medicine Affiliated Ninth People’s Hospital | China

Wei Cao, MD, PhD, is a distinguished Professor at the Department of Oral and Maxillofacial–Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine. Renowned for his expertise in head and neck cancers, especially oral squamous cell carcinoma, he has contributed significantly to understanding tumor biology, recurrence mechanisms, and therapeutic resistance. With an H-index of and citations, he has authored impactful research shaping the field of oral oncology. His editorial appointments in high-impact journals and active membership in global medical associations further reflect his academic stature and leadership in oncology research.

Profile

Scopus | Orcid

Education

Wei Cao earned his Diploma in Oral Medicine from Zhengzhou University School of Medicine. He then pursued his MD and PhD at Shanghai Jiao Tong University School of Medicine, completing his doctoral training in Head and Neck Surgical Oncology in. To enhance his research scope and gain international exposure, he undertook postgraduate training in the Department of Oncology and Diagnostic Sciences at the University of Maryland Dental School in the USA. His educational journey has provided him with a strong foundation in both clinical practice and biomedical research.

Experience

Over his career, Wei Cao has progressed through academic and clinical ranks, starting as a Fellow in the Department of Oral and Maxillofacial–Head and Neck Oncology and later serving as a Surgeon  in the same department. He was appointed Associate Professor in and Consultant before becoming Professor. Alongside his hospital responsibilities, he plays key editorial roles in journals such as Frontiers in Oncology and Technology in Cancer Research & Treatment, and serves on multiple editorial boards including BMC Cancer and Cancer Biology & Medicine. His professional affiliations include the American Association for Cancer Research and the Royal Society of Medicine.

Research Interest

Cao’s research focuses on the molecular mechanisms underlying the initiation, progression, and recurrence of oral and head and neck cancers. He investigates tumor microenvironment interactions, immunotherapy responses, and the role of non-coding RNAs in cancer biology. His work also explores novel biomarkers for prognosis, mechanisms of therapy resistance, and the development of personalized treatment strategies. Integrating single-cell transcriptomics, molecular pathology, and clinical data, his research aims to improve survival outcomes and quality of life for cancer patients.

Award

Wei Cao’s research excellence has been recognized with numerous honors, including the CYTO Student Travel Award, Excellent Doctoral Dissertation in Shanghai, and multiple national and institutional science and technology awards such as the 2nd Prize from the Chinese Medical Association and the National Ministry of Education.he was named among the “Outstanding Young Oncologists” by the Chinese Society of Clinical Oncology and received the Outstanding Young Scholar and Kowloon Outstanding Young Talent Awards from Shanghai Jiao Tong University School of Medicine.

Publication Top Notes

Cao has an extensive publication record in high-impact journals. Seven representative works include:

Title:  Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma,” Int J Oral Sci.
Year: 2024
Citations: 2

Title:  LINC02454-CCT complex interaction is essential for telomerase activity and cell proliferation in head and neck squamous cell carcinoma, Cancer Lett.
Year: 2024
Citations: 3

Title:  CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma,” Int J Immunopathol Pharmacol.
Year: 2024
Citations: 1

Title:  Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation, Adv Sci (Weinh).
Year: 2023
Citations: 6

Title:  EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma,” Biomolecules.
Year: 2023
Citations: 5

Title:  Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments, Cell Metab.
Year: 2022
Citations: 44

Title: Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance, Oral Dis.
Year: 2023
Citations: 8

Conclusion

Professor Wei Cao has established himself as a leader in oral and head and neck oncology through a career that bridges clinical excellence and groundbreaking research. His contributions to elucidating molecular mechanisms, identifying prognostic biomarkers, and advancing therapeutic strategies have significantly impacted patient care and cancer biology. With a robust portfolio of high-impact publications, prestigious awards, and leadership roles in international journals, he continues to shape the future of cancer research. His work reflects a commitment to innovation, interdisciplinary collaboration, and improving clinical outcomes for patients facing complex oncological challenges.